查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1743730

兽医静脉注射解决方案市场－全球产业规模、份额、趋势、机会和预测，按产品、适应症、动物类型、最终用途、地区和竞争细分，2020-2030 年

Veterinary Intravenous Solutions Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Indication, By Animal type, By End Use, By Region & Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3个工作天内

价格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

简介目录

2024年，全球兽医静脉注射 (IV) 解决方案市场规模达13.5亿美元，预计将大幅扩张，到2030年将达到新高，预测期内的复合年增长率为6.57%。这一增长反映了兽医学的进步，也反映了人类医疗保健的趋势，其中静脉注射解决方案已成为治疗方案中不可或缺的一部分。兽医静脉注射解决方案对于各种动物的补液、药物输送和重症监护都至关重要。全球宠物拥有量的增加、人们对动物照护期望值的提高以及投保宠物数量的增加（例如，2024年北美报告的投保宠物数量为625万隻）是推动这一需求激增的主要因素。这些解决方案可用于常规和紧急情况，在兽医环境中支持復健和治疗效果。随着人类与动物之间联繫的加深以及宠物护理的日益复杂，对可靠、有效的静脉注射疗法的需求持续增长，推动着全球市场的扩张。

市场概览
预测期 2026-2030
2024年市场规模 13.5亿美元
2030年市场规模 19.6亿美元
2025-2030 年复合年增长率 6.57%
成长最快的领域 伴侣动物
最大的市场 北美洲

关键市场驱动因素

宠物拥有量和人性化程度的提高正在推动全球兽医静脉注射（IV）解决方案市场的发展

主要市场挑战

研究和配方种类有限对市场扩张构成重大障碍

主要市场趋势

技术进步

目录

第 1 章：产品概述

第二章：研究方法

第三章：执行摘要

第四章：顾客之声

第五章：全球兽医静脉注射（IV）解决方案市场展望

  • 市场规模和预测
    • 按价值
  • 市场占有率和预测
    • 副产品（等渗晶体、合成胶体、血液製品、葡萄糖溶液、肠外营养）
    • 依适应症（糖尿病酮酸中毒、胰臟炎、炭疽病、慢性肾臟病、其他）
    • 依动物类型（伴侣动物、生产动物）
    • 依最终用途（兽医院、研究机构、其他）
    • 按地区
    • 按公司分类（前五大市场参与者的股份）
  • 市场地图
    • 按产品
    • 按适应症
    • 依动物类型
    • 按最终用途
    • 按地区

第六章：北美兽医静脉注射（IV）溶液市场展望

  • 市场规模和预测
  • 市场占有率和预测

第七章：欧洲兽用静脉注射（IV）溶液市场展望

  • 市场规模和预测
  • 市场占有率和预测

第八章：亚太地区兽用静脉注射（IV）解决方案市场展望

  • 市场规模和预测
  • 市场占有率和预测

第九章：南美洲兽医静脉注射（IV）溶液市场展望

  • 市场规模和预测
  • 市场占有率和预测

第 10 章：中东和非洲兽医静脉注射（IV）解决方案市场展望

  • 市场规模和预测
  • 市场占有率和预测

第 11 章：市场动态

  • 驱动程式
  • 挑战

第 12 章：市场趋势与发展

  • 近期发展
  • 併购
  • 产品发布

第 13 章：竞争格局

  • Merck & Co., Inc.
  • Dechra Veterinary Products
  • Sypharma
  • Animalcare
  • B. Braun SE
  • Woods Consulting, LLC
  • Baxter International
  • Fresenius Kabi

第 14 章：策略建议

第15章调查会社について・免责事项

简介目录
Product Code: 16229

The Global Veterinary Intravenous (IV) Solutions Market was valued at USD 1.35 billion in 2024 and is projected to expand significantly, reaching new heights by 2030 with a CAGR of 6.57% during the forecast period. This growth reflects advancements in veterinary medicine, mirroring trends in human healthcare, where IV solutions are integral to treatment protocols. Veterinary IV solutions are crucial for hydration, medication delivery, and critical care across a variety of animal species. Increasing global pet ownership, heightened expectations for animal care, and the growing number of insured pets-such as the 6.25 million pets reported insured in North America in 2024-are major contributors to this surge in demand. These solutions are used in both routine and emergency situations, supporting recovery and treatment efficacy in veterinary settings. As the human-animal bond deepens and pet care becomes more sophisticated, the need for reliable, effective IV therapies continues to grow, driving market expansion worldwide.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 1.35 Billion
Market Size 2030USD 1.96 Billion
CAGR 2025-20306.57%
Fastest Growing SegmentCompanion Animal
Largest MarketNorth America

Key Market Drivers

Rising Pet Ownership and Humanization is Driving the Global Veterinary Intravenous (IV) Solutions Market

The rapid increase in global pet ownership and the growing trend of treating pets as family members are significantly boosting demand for veterinary healthcare services, including IV solutions. In the U.S., approximately 67% of households own a pet, a trend echoed in many other regions. This humanization of pets has transformed the way owners approach healthcare, prompting greater interest in advanced medical treatments similar to those used for humans. Veterinary IV solutions, vital for administering fluids, medications, and nutrients during critical care, are increasingly in demand as pet owners seek comprehensive and high-quality medical support. The surge in pet insurance coverage also supports this growth by making advanced veterinary treatments more financially accessible, encouraging more pet owners to opt for intensive interventions that include IV therapy.

Key Market Challenges

Limited Research and Formulation Variety Poses a Significant Obstacle To Market Expansion

A significant challenge facing the veterinary IV solutions market is the limited research and formulation diversity tailored to various animal species. Unlike human IV solutions, which benefit from extensive R&D and specificity, veterinary formulations often lack the same level of customization. This is particularly problematic for exotic and less common species that have unique physiological needs not addressed by standard formulations. The limited number of species-specific products restricts veterinarians' ability to deliver optimal care, which can impact treatment outcomes. This gap in product variety hinders market expansion and highlights the need for increased investment in research to develop a broader range of targeted IV solutions across diverse animal categories.

Key Market Trends

Technological Advancements

The integration of precision medicine and digital health technologies is reshaping the veterinary IV solutions market. Diagnostic innovations, such as genetic testing, allow for the formulation of personalized IV therapies, improving treatment effectiveness and patient outcomes. Telemedicine platforms and remote monitoring tools are also revolutionizing care delivery, enabling veterinarians to track patient vitals and modify IV regimens in real time without in-person visits. Moreover, smart infusion pumps and automated delivery systems enhance accuracy and safety by precisely controlling fluid and medication administration. These systems can adapt dosages dynamically based on live data. The adoption of digital health records and analytics further supports data-driven treatment decisions, improving care outcomes and contributing to the evolution of more targeted, efficient, and intelligent veterinary healthcare protocols.

Key Market Players

  • Merck & Co., Inc.
  • Dechra Veterinary Products
  • Sypharma Pty Ltd.
  • Animalcare group plc
  • Braun SE
  • Woods Consulting, LLC
  • Baxter International
  • Fresenius Kabi

Report Scope:

In this report, the Global Veterinary Intravenous (IV) Solutions Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Veterinary Intravenous (IV) Solutions Market, By Product:

  • Isotonic crystalloids
  • Synthetic colloids
  • Blood products
  • Dextrose solutions
  • Parenteral nutrition

Veterinary Intravenous (IV) Solutions Market, By Indication:

  • Diabetic Ketoacidosis
  • Pancreatitis
  • Anthrax
  • Chronic Kidney Disease
  • Others

Veterinary Intravenous (IV) Solutions Market, By Animal Type:

  • Companion Animals
  • Production Animals

Veterinary Intravenous (IV) Solutions Market, By End Use:

  • Veterinary Hospitals
  • Research Institutes
  • Others

Veterinary Intravenous (IV) Solutions Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia-Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Intravenous (IV) Solutions Market.

Available Customizations:

Global Veterinary Intravenous (IV) Solutions Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Veterinary Intravenous (IV) Solutions Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Isotonic crystalloids, Synthetic colloids, Blood products, Dextrose solutions, Parenteral nutrition)
    • 5.2.2. By Indication (Diabetic Ketoacidosis, Pancreatitis, Anthrax, Chronic Kidney Disease, Others)
    • 5.2.3. By Animal type (Companion Animals, Production Animals)
    • 5.2.4. By End Use (Veterinary Hospitals, Research Institutes, Others)
    • 5.2.5. By Region
    • 5.2.6. By Company (Shares of Top 5 Market Players)
  • 5.3. Market Map
    • 5.3.1. By Product
    • 5.3.2. By Indication
    • 5.3.3. By Animal type
    • 5.3.4. By End Use
    • 5.3.5. By Region

6. North America Veterinary Intravenous (IV) Solutions Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Indication
    • 6.2.3. By Animal type
    • 6.2.4. By End Use
    • 6.2.5. By Country
      • 6.2.5.1. United States Veterinary Intravenous (IV) Solutions Market Outlook
        • 6.2.5.1.1. Market Size & Forecast
        • 6.2.5.1.1.1. By Value
        • 6.2.5.1.2. Market Share & Forecast
        • 6.2.5.1.2.1. By Product
        • 6.2.5.1.2.2. By Indication
        • 6.2.5.1.2.3. By Animal type
        • 6.2.5.1.2.4. By End Use
      • 6.2.5.2. Canada Veterinary Intravenous (IV) Solutions Market Outlook
        • 6.2.5.2.1. Market Size & Forecast
        • 6.2.5.2.1.1. By Value
        • 6.2.5.2.2. Market Share & Forecast
        • 6.2.5.2.2.1. By Product
        • 6.2.5.2.2.2. By Indication
        • 6.2.5.2.2.3. By Animal type
        • 6.2.5.2.2.4. By End Use
      • 6.2.5.3. Mexico Veterinary Intravenous (IV) Solutions Market Outlook
        • 6.2.5.3.1. Market Size & Forecast
        • 6.2.5.3.1.1. By Value
        • 6.2.5.3.2. Market Share & Forecast
        • 6.2.5.3.2.1. By Product
        • 6.2.5.3.2.2. By Indication
        • 6.2.5.3.2.3. By Animal type
        • 6.2.5.3.2.4. By End Use

7. Europe Veterinary Intravenous (IV) Solutions Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Indication
    • 7.2.3. By Animal type
    • 7.2.4. By End Use
    • 7.2.5. By Country
      • 7.2.5.1. France Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.1.1. Market Size & Forecast
        • 7.2.5.1.1.1. By Value
        • 7.2.5.1.2. Market Share & Forecast
        • 7.2.5.1.2.1. By Product
        • 7.2.5.1.2.2. By Indication
        • 7.2.5.1.2.3. By Animal type
        • 7.2.5.1.2.4. By End Use
      • 7.2.5.2. Germany Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.2.1. Market Size & Forecast
        • 7.2.5.2.1.1. By Value
        • 7.2.5.2.2. Market Share & Forecast
        • 7.2.5.2.2.1. By Product
        • 7.2.5.2.2.2. By Indication
        • 7.2.5.2.2.3. By Animal type
        • 7.2.5.2.2.4. By End Use
      • 7.2.5.3. United Kingdom Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.3.1. Market Size & Forecast
        • 7.2.5.3.1.1. By Value
        • 7.2.5.3.2. Market Share & Forecast
        • 7.2.5.3.2.1. By Product
        • 7.2.5.3.2.2. By Indication
        • 7.2.5.3.2.3. By Animal type
        • 7.2.5.3.2.4. By End Use
      • 7.2.5.4. Italy Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.4.1. Market Size & Forecast
        • 7.2.5.4.1.1. By Value
        • 7.2.5.4.2. Market Share & Forecast
        • 7.2.5.4.2.1. By Product
        • 7.2.5.4.2.2. By Indication
        • 7.2.5.4.2.3. By Animal type
        • 7.2.5.4.2.4. By End Use
      • 7.2.5.5. Spain Veterinary Intravenous (IV) Solutions Market Outlook
        • 7.2.5.5.1. Market Size & Forecast
        • 7.2.5.5.1.1. By Value
        • 7.2.5.5.2. Market Share & Forecast
        • 7.2.5.5.2.1. By Product
        • 7.2.5.5.2.2. By Indication
        • 7.2.5.5.2.3. By Animal type
        • 7.2.5.5.2.4. By End Use

8. Asia Pacific Veterinary Intravenous (IV) Solutions Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Indication
    • 8.2.3. By Animal type
    • 8.2.4. By End Use
    • 8.2.5. By Country
      • 8.2.5.1. China Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.1.1. Market Size & Forecast
        • 8.2.5.1.1.1. By Value
        • 8.2.5.1.2. Market Share & Forecast
        • 8.2.5.1.2.1. By Product
        • 8.2.5.1.2.2. By Indication
        • 8.2.5.1.2.3. By Animal type
        • 8.2.5.1.2.4. By End Use
      • 8.2.5.2. India Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.2.1. Market Size & Forecast
        • 8.2.5.2.1.1. By Value
        • 8.2.5.2.2. Market Share & Forecast
        • 8.2.5.2.2.1. By Product
        • 8.2.5.2.2.2. By Indication
        • 8.2.5.2.2.3. By Animal type
        • 8.2.5.2.2.4. By End Use
      • 8.2.5.3. South Korea Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.3.1. Market Size & Forecast
        • 8.2.5.3.1.1. By Value
        • 8.2.5.3.2. Market Share & Forecast
        • 8.2.5.3.2.1. By Product
        • 8.2.5.3.2.2. By Indication
        • 8.2.5.3.2.3. By Animal type
        • 8.2.5.3.2.4. By End Use
      • 8.2.5.4. Japan Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.4.1. Market Size & Forecast
        • 8.2.5.4.1.1. By Value
        • 8.2.5.4.2. Market Share & Forecast
        • 8.2.5.4.2.1. By Product
        • 8.2.5.4.2.2. By Indication
        • 8.2.5.4.2.3. By Animal type
        • 8.2.5.4.2.4. By End Use
      • 8.2.5.5. Australia Veterinary Intravenous (IV) Solutions Market Outlook
        • 8.2.5.5.1. Market Size & Forecast
        • 8.2.5.5.1.1. By Value
        • 8.2.5.5.2. Market Share & Forecast
        • 8.2.5.5.2.1. By Product
        • 8.2.5.5.2.2. By Indication
        • 8.2.5.5.2.3. By Animal type
        • 8.2.5.5.2.4. By End Use

9. South America Veterinary Intravenous (IV) Solutions Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Indication
    • 9.2.3. By Animal type
    • 9.2.4. By End Use
    • 9.2.5. By Country
      • 9.2.5.1. Brazil Veterinary Intravenous (IV) Solutions Market Outlook
        • 9.2.5.1.1. Market Size & Forecast
        • 9.2.5.1.1.1. By Value
        • 9.2.5.1.2. Market Share & Forecast
        • 9.2.5.1.2.1. By Product
        • 9.2.5.1.2.2. By Indication
        • 9.2.5.1.2.3. By Animal type
        • 9.2.5.1.2.4. By End Use
      • 9.2.5.2. Argentina Veterinary Intravenous (IV) Solutions Market Outlook
        • 9.2.5.2.1. Market Size & Forecast
        • 9.2.5.2.1.1. By Value
        • 9.2.5.2.2. Market Share & Forecast
        • 9.2.5.2.2.1. By Product
        • 9.2.5.2.2.2. By Indication
        • 9.2.5.2.2.3. By Animal type
        • 9.2.5.2.2.4. By End Use
      • 9.2.5.3. Colombia Veterinary Intravenous (IV) Solutions Market Outlook
        • 9.2.5.3.1. Market Size & Forecast
        • 9.2.5.3.1.1. By Value
        • 9.2.5.3.2. Market Share & Forecast
        • 9.2.5.3.2.1. By Product
        • 9.2.5.3.2.2. By Indication
        • 9.2.5.3.2.3. By Animal type
        • 9.2.5.3.2.4. By End Use

10. Middle East & Africa Veterinary Intravenous (IV) Solutions Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Indication
    • 10.2.3. By Animal type
    • 10.2.4. By End Use
    • 10.2.5. By Country
      • 10.2.5.1. South Africa Veterinary Intravenous (IV) Solutions Market Outlook
        • 10.2.5.1.1. Market Size & Forecast
        • 10.2.5.1.1.1. By Value
        • 10.2.5.1.2. Market Share & Forecast
        • 10.2.5.1.2.1. By Product
        • 10.2.5.1.2.2. By Indication
        • 10.2.5.1.2.3. By Animal type
        • 10.2.5.1.2.4. By End Use
      • 10.2.5.2. Saudi Arabia Veterinary Intravenous (IV) Solutions Market Outlook
        • 10.2.5.2.1. Market Size & Forecast
        • 10.2.5.2.1.1. By Value
        • 10.2.5.2.2. Market Share & Forecast
        • 10.2.5.2.2.1. By Product
        • 10.2.5.2.2.2. By Indication
        • 10.2.5.2.2.3. By Animal type
        • 10.2.5.2.2.4. By End Use
      • 10.2.5.3. UAE Veterinary Intravenous (IV) Solutions Market Outlook
        • 10.2.5.3.1. Market Size & Forecast
        • 10.2.5.3.1.1. By Value
        • 10.2.5.3.2. Market Share & Forecast
        • 10.2.5.3.2.1. By Product
        • 10.2.5.3.2.2. By Indication
        • 10.2.5.3.2.3. By Animal type
        • 10.2.5.3.2.4. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Competitive Landscape

  • 13.1. Merck & Co., Inc.
    • 13.1.1. Business Overview
    • 13.1.2. Company Snapshot
    • 13.1.3. Products & Service
    • 13.1.4. Financials (As Reported)
    • 13.1.5. Recent Developments
    • 13.1.6. Key Personnel Details
    • 13.1.7. SWOT Analysis
  • 13.2. Dechra Veterinary Products
  • 13.3. Sypharma
  • 13.4. Animalcare
  • 13.5. B. Braun SE
  • 13.6. Woods Consulting, LLC
  • 13.7. Baxter International
  • 13.8. Fresenius Kabi

14. Strategic Recommendations

15. About us & Disclaimer